Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/17/2018 |
Start Date: | August 2016 |
End Date: | December 2018 |
Contact: | Stephen Roach |
Email: | Stephen.Roach@wright.com |
Phone: | 615-656-7466 |
A Prospective, Controlled, Multi-Center, Post-Approval Trial to Evaluate the Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Foot and Ankle Fusions
The objective of this long-term study is to evaluate the long term effectiveness and safety
of AUGMENT® Bone Graft vs. autologous bone graft. The study involves evaluation of subjects
originally treated under Protocol BMTI-2006-01.
Subjects will be asked to consent and return to provide long-term follow-up data at or after
60 months (5 years) have elapsed since their original surgery as a subject in protocol
BMTI-2006-01.
STUDY HYPOTHESIS: The effectiveness and safety profile for AUGMENT® Bone Graft is maintained
and remains comparable to that of autologous bone graft over long-term subject follow-up.
REGULATORY PHASE: Post-approval study
of AUGMENT® Bone Graft vs. autologous bone graft. The study involves evaluation of subjects
originally treated under Protocol BMTI-2006-01.
Subjects will be asked to consent and return to provide long-term follow-up data at or after
60 months (5 years) have elapsed since their original surgery as a subject in protocol
BMTI-2006-01.
STUDY HYPOTHESIS: The effectiveness and safety profile for AUGMENT® Bone Graft is maintained
and remains comparable to that of autologous bone graft over long-term subject follow-up.
REGULATORY PHASE: Post-approval study
Inclusion Criteria:
Subjects who meet the following criteria may be included in the study:
1. Must be willing and able to provide informed consent and be available for the planned
follow-up evaluations and radiologic tests; and
2. Must have been randomized, treated and included in the safety population of Protocol
BMTI-2006-01 (see Exhibit 13.1).
Exclusion Criteria:
1) Subjects that were excluded from the safety analysis in the BMTI-2006-01 study (subjects
not listed in Exhibit 13.1). These subjects were consented, but never treated as part of
the BMTI-2006-01 protocol.
We found this trial at
22
sites
Glenview, Illinois 60025
Principal Investigator: Steven Haddad, MD
Phone: 847-998-5680
Click here to add this to my saved trials
9500 Euclid Avenue
Cleveland, Ohio 44106
Cleveland, Ohio 44106
216.444.2200
Principal Investigator: Mark Berkowitz, M.D.
Phone: 216-444-5436
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
Click here to add this to my saved trials
1200 Moursund Street
Houston, Texas 77030
Houston, Texas 77030
(713) 798-4951
Principal Investigator: William Granberry, MD
Phone: 832-355-3710
Baylor College of Medicine Baylor College of Medicine in Houston, the only private medical school...
Click here to add this to my saved trials
60 Crittenden Blvd # 70
Rochester, New York 14642
Rochester, New York 14642
(585) 275-2121
Principal Investigator: Judith Baumhauer, MD
Phone: 585-341-0556
University of Rochester The University of Rochester is one of the country's top-tier research universities....
Click here to add this to my saved trials
Baltimore, Maryland 21218
Principal Investigator: Lew Schon, M.D.
Phone: 410-554-4451
Click here to add this to my saved trials
Click here to add this to my saved trials
2225 Macleod Trail Southeast
Calgary, Alberta T2G 5B6
Calgary, Alberta T2G 5B6
Principal Investigator: Ian Le, MD
Phone: 403-671-8645
Click here to add this to my saved trials
4140 Jade Street
Capitola, California 95010
Capitola, California 95010
Principal Investigator: Nicholas Abidi, MD
Phone: 831-475-4024
Click here to add this to my saved trials
Charlotte, North Carolina 28207
Principal Investigator: Robert Anderson, MD
Phone: 704-323-2266
Click here to add this to my saved trials
Durham, North Carolina
Principal Investigator: Mark Easley, M.D.
Phone: 919-668-9175
Click here to add this to my saved trials
2922 Telestar Court
Falls Church, Virginia 22042
Falls Church, Virginia 22042
Principal Investigator: Steven Neufeld, MD
Phone: 703-584-2040
Click here to add this to my saved trials
Germantown, Tennessee 38138
Principal Investigator: Andrew Murphy, MD
Phone: 901-435-5705
Click here to add this to my saved trials
Grand Rapids, Michigan 49525
Principal Investigator: John Anderson, MD
Phone: 616-459-7101
Click here to add this to my saved trials
80 Seymour St
Hartford, Connecticut 6102
Hartford, Connecticut 6102
(860) 545-5000
Principal Investigator: Raymond Sullivan, MD
Phone: 860-972-5311
The Hartford Hospital Hartford Hospital is the major teaching hospital affiliated with the University of...
Click here to add this to my saved trials
2815 South Pennsylvania Avenue
Lansing, Michigan 48910
Lansing, Michigan 48910
Principal Investigator: Michael Swords, MD
Phone: 517-267-0200
Click here to add this to my saved trials
2800 East Desert Inn Road
Las Vegas, Nevada 89121
Las Vegas, Nevada 89121
Principal Investigator: Troy Watson, MD
Phone: 702-731-1616
Click here to add this to my saved trials
Newark, New Jersey 07103
Principal Investigator: Sheldon Lin, M.D.
Phone: 973-972-5435
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19107
Principal Investigator: Steven Raikin, MD
Phone: 267-339-3613
Click here to add this to my saved trials
Royal Palm Beach, Florida 33411
Principal Investigator: Robert Rochman, MD
Phone: 561-633-4241
Click here to add this to my saved trials
45 Castro Street
San Francisco, California 94114
San Francisco, California 94114
(415) 600-6000
Principal Investigator: Keith Donatto, M.D.
Phone: 415-600-3148
California Pacific Medical Center California Pacific Medical Center is one of the largest private, not-for-profit,...
Click here to add this to my saved trials
5301 East Grant Road
Tucson, Arizona 85172
Tucson, Arizona 85172
Principal Investigator: Nebojsa Skrepnik, MD
Phone: 520-784-6446
Click here to add this to my saved trials
Westerville, Ohio 43082
Principal Investigator: Gregory Berlet, M.D.
Phone: 614-895-2424
Click here to add this to my saved trials